KaloBios Pharmaceuticals IPO Research Information

KaloBios Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on KaloBios Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
KaloBios Pharmaceuticals	KBIO -	$12.00-$14.00	$8.00	$8.16	8.75 million	1/31/2013
Underwriter(s): Leerink Swann
Co-Manager(s): William Blair, Needham & Co.
Industry: Health Care
Filing(s): Filed 2012-10-05

KaloBios Pharmaceuticals Quote & Chart - Click for current quote - KBIO

About KaloBios Pharmaceuticals (adapted from KaloBios Pharmaceuticals prospectus):
They are a biopharmaceutical company focused on the development of monoclonal antibody therapeutics for diseases that represent a significant burden to society and to patients and their families.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "KBIO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.